蝨子治疗药物市场规模、份额和成长分析（按产品类型、给药途径、症状、剂型、分销管道和地区）-产业预测（2025-2032）

2023 年全球蝨子治疗药物市场规模为 22 亿美元，预计将从 2024 年的 23.5 亿美元增长到 2032 年的 40.1 亿美元，预测期内（2025-2032 年）的复合年增长率为 6.9%。

蝨子治疗药物市场预计将蓬勃发展，这得益于多个关键因素，例如蝨子患病率的上升、非处方药的便捷获取以及治疗配方的创新进步。政府的健康倡议以及人们对天然无毒产品的日益偏好，进一步推动了全球市场的需求。在学校等拥挤的环境中，蝨子发病率不断上升，加之线上零售平台的便利性提升，产品供应也随之增加，这为企业拓展市场提供了机会。然而，到2032年，诸如化学疗法抗药性日益增强、潜在的副作用、低收入地区获取药物的管道有限以及社会歧视等挑战可能会阻碍市场渗透。综上所述，这些见解凸显了蝨子治疗药物领域的成长潜力和限制。

目录

介绍

• 分析目的
• 市场覆盖
• 定义

分析方法

• 资讯采购
• 二次资料和一次资料方法
• 市场规模预测
• 市场假设与约束

执行摘要

• 市场概况与展望
• 供需趋势分析
• 按细分市场进行机会分析

市场动态与展望

• 市场概览
• 市场规模
• 市场动态
  • 驱动因素和机会
  • 限制与挑战
• 波特的分析

关键市场观察

• 关键成功因素
• 竞争程度
• 主要投资机会
• 市场生态系统
• 市场魅力指数（2024年）
• PESTEL分析
• 总体经济指标
• 价值链分析
• 定价分析

全球蝨子治疗市场规模及复合年增长率（按产品类型）（2025-2032 年）

• 市场概览
• 非处方药
  • Permethrin
  • 除虫菊酯
  • 其他非处方药
• 处方药
  • 伊维菌素
  • 多杀菌素
  • Malathion
  • 其他处方药

全球蝨子治疗市场规模及复合年增长率（按类型）（2025-2032）

• 市场概览
• 品牌
• 非专利的

全球蝨子治疗市场规模及依给药途径分類的复合年增长率（2025-2032 年）

• 市场概览
• 口服
• 外用药物

全球蝨子治疗市场规模及复合年增长率（按症状划分）（2025-2032 年）

• 市场概览
• 头蝨感染
• 体蝨感染
• 阴蝨

全球蝨子治疗市场规模及复合年增长率（按剂型划分）（2025-2032 年）

• 市场概览
• 药片
• 洗髮精
• 洗剂
• 奶油
• 其他剂型

全球蝨子治疗市场规模及按分销管道分類的复合年增长率（2025-2032 年）

• 市场概览
• 医院药房
• 零售药局
• 其他分销管道

全球蝨子治疗市场规模及复合年增长率（2025-2032）

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲国家地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 其他亚太地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲
• 中东和非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东和非洲地区

竞争格局

• 前五大公司对比
• 主要企业市场定位（2024年）
• 主要企业采取的策略
• 近期市场趋势
• 主要企业市场占有率（2024年）
• 主要企业简介
  • 公司简介
  • 产品系列分析
  • 按细分市场分析市场份额
  • 收益与前一年同期比较对比（2022-2024 年）

主要企业简介

• Johnson & Johnson Services, Inc.（USA）
• Reckitt Benckiser Group plc（UK）
• Perrigo Company plc（Ireland）
• Prestige Consumer Healthcare Inc.（USA）
• Sanofi SA（France）
• GlaxoSmithKline（GSK）plc（UK）
• Teva Pharmaceutical Industries Ltd.（Israel）
• Pfizer Inc.（USA）
• F. Hoffmann-La Roche Ltd.（Switzerland）
• Sun Pharmaceutical Industries Ltd.（India）
• ParaPRO LLC.（USA）
• Alliance Pharma PLC（UK）
• Arbor Pharmaceuticals, LLC.（USA）
• Oystershell Consumer Health（Belgium）
• Taro Pharmaceuticals（Canada）
• ICB PHARMA（Poland）
• Lice Clinics of America（USA）

结论和建议

Global Lice Treatment Market size was valued at USD 2.2 billion in 2023 and is poised to grow from USD 2.35 billion in 2024 to USD 4.01 billion by 2032, growing at a CAGR of 6.9% during the forecast period (2025-2032).

The lice treatment market is expected to flourish due to several key factors, including the rising prevalence of lice infestations, easy access to over-the-counter treatments, and innovative advancements in treatment formulations. Government health initiatives and a growing preference for natural, non-toxic products further bolster global market demand. Increased occurrences of lice in overcrowded environments, like schools, alongside the convenience of online retail platforms, enhance product accessibility and market expansion opportunities for companies. However, challenges such as rising resistance to chemical treatments, potential side effects, limited access in low-income areas, and social stigma may hinder market penetration through 2032. Collectively, these insights highlight both the growth potential and limitations within the lice treatment sector.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Lice Treatment market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Lice Treatment Market Segments Analysis

Global Lice Treatment Market is segmented by Product Type, Type, Route of Administration, Condition, Dosage Form, Distribution Channel and region. Based on Product Type, the market is segmented into OTC products and Prescription medications. Based on Type, the market is segmented into Branded and Generic. Based on Route of Administration, the market is segmented into Oral and Topical. Based on Condition, the market is segmented into Pediculosis capitis, Pediculosis corporis and Pediculosis pubis. Based on Dosage Form, the market is segmented into Tablets, Shampoos, Lotions, Cream and Other dosage forms. Based on Distribution Channel, the market is segmented into Hospital pharmacies, Retail pharmacies and Other distribution channels. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Lice Treatment Market

The Global Lice Treatment market is being propelled by innovations in treatment formulations that significantly enhance both effectiveness and user safety. Modern products, particularly those that are non-pesticide and silicone-based, effectively immobilize lice without relying on neurotoxins, thereby minimizing the risk of resistance. These advanced treatments are often odorless, cause less irritation, and require shorter application times, which ultimately improves the user experience. As a result, consumers are more likely to trust and feel satisfied with these options, leading to increased repeat purchases and positively impacting the market's growth trajectory in the coming years.

Restraints in the Global Lice Treatment Market

The global lice treatment market faces significant restraints due to the increasing resistance of lice to commonly used treatments. Chemical agents like permethrin and pyrethrin, which were once effective, have lost their potency due to overuse, resulting in treatment failures that frustrate consumers and lead to a decline in brand trust and repeat purchases. The emergence of "super lice," which are resistant to multiple chemical formulations, further complicates treatment options and underscores the need for alternative solutions. As a result, the growing demand for non-chemical treatments has contributed to a slowdown in the overall growth of the lice treatment industry.

Market Trends of the Global Lice Treatment Market

The Global Lice Treatment market is witnessing a significant trend towards preventive care, shifting from traditional reactive treatments to proactive measures. Parents and educational institutions are increasingly prioritizing strategies aimed at preventing lice infestations, resulting in heightened demand for products such as lice-repelling shampoos, sprays, and combs, especially those enriched with essential oils like rosemary and eucalyptus. This focus on prevention is not only broadening the product offering but also encouraging consumers to adopt consistent, long-term usage patterns. As awareness around lice prevention grows, the global market is expected to expand, catering to a more health-conscious demographic seeking effective solutions to combat lice infestations.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis

Global Lice Treatment Market Size by Product Type & CAGR (2025-2032)

• Market Overview
• OTC products
  • Permethrin
  • Pyrethrin
  • Other OTC products
• Prescription medications
  • Ivermectin
  • Spinosad
  • Malathion
  • Other prescription medications

Global Lice Treatment Market Size by Type & CAGR (2025-2032)

• Market Overview
• Branded
• Generic

Global Lice Treatment Market Size by Route of Administration & CAGR (2025-2032)

• Market Overview
• Oral
• Topical

Global Lice Treatment Market Size by Condition & CAGR (2025-2032)

• Market Overview
• Pediculosis capitis
• Pediculosis corporis
• Pediculosis pubis

Global Lice Treatment Market Size by Dosage Form & CAGR (2025-2032)

• Market Overview
• Tablets
• Shampoos
• Lotions
• Cream
• Other dosage forms

Global Lice Treatment Market Size by Distribution Channel & CAGR (2025-2032)

• Market Overview
• Hospital pharmacies
• Retail pharmacies
• Other distribution channels

Global Lice Treatment Market Size & CAGR (2025-2032)

• North America (Product Type, Type, Route of Administration, Condition, Dosage Form, Distribution Channel)
  • US
  • Canada
• Europe (Product Type, Type, Route of Administration, Condition, Dosage Form, Distribution Channel)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product Type, Type, Route of Administration, Condition, Dosage Form, Distribution Channel)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product Type, Type, Route of Administration, Condition, Dosage Form, Distribution Channel)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product Type, Type, Route of Administration, Condition, Dosage Form, Distribution Channel)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Johnson & Johnson Services, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Reckitt Benckiser Group plc (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Perrigo Company plc (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Prestige Consumer Healthcare Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sanofi S.A. (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GlaxoSmithKline (GSK) plc (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Teva Pharmaceutical Industries Ltd. (Israel)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pfizer Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• F. Hoffmann-La Roche Ltd. (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sun Pharmaceutical Industries Ltd. (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ParaPRO LLC. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Alliance Pharma PLC (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Arbor Pharmaceuticals, LLC. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Oystershell Consumer Health (Belgium)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Taro Pharmaceuticals (Canada)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ICB PHARMA (Poland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Lice Clinics of America (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations